Paroxysmal Supraventricular Tachycardia
📧 Sign up to get email alerts when something new happens for Paroxysmal Supraventricular Tachycardia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-12-13FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for diltiazem hydrochloride filed by Hospira, Inc., signaling an additional approval related to the …
-
FDA approval · 2017-11-27FDA Approved: ADENOSINE — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original application for Adenosine from Fresenius Kabi USA, LLC for injection. The product is used to interrupt paroxysmal …
-
FDA approval · 2017-11-17FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for verapamil hydrochloride from Chartwell RX, LLC.
-
FDA approval · 2017-11-02FDA Approved: ADENOSINE — Original Application (Eugia US LLC)
FDA approves a generic adenosine product under Original Application (ANDA205331) by Eugia US LLC.
-
FDA approval · 2017-05-05FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Nivagen Pharmaceuticals, Inc.)
The FDA approved the original application for verapamil hydrochloride from Nivagen Pharmaceuticals, Inc. as a generic product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-11-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Wilshire Pharmaceuticals, Inc.)
FDA approved a supplemental application for verapamil hydrochloride from Wilshire Pharmaceuticals, Inc., updating the existing NDA.
-
FDA approval · 2016-11-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (EXELA PHARMA SCIENCES, LLC)
The FDA approved a supplemental application for verapamil hydrochloride from Exela Pharma Sciences, LLC.
-
FDA approval · 2016-05-11FDA Approved: PROPAFENONE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for propafenone hydrochloride (generic) manufactured by Aurobindo Pharma Limited.
-
FDA approval · 2016-04-08FDA Approved: ADENOSINE — Supplemental Application (Mylan Institutional LLC)
The FDA approved a supplemental application for Adenosine submitted by Mylan Institutional LLC.
-
FDA approval · 2015-10-26FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for verapamil hydrochloride (Actavis Pharma, Inc.), a generic product.
-
FDA approval · 2015-08-27FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved Strides Pharma Science Limited's supplemental application for propafenone hydrochloride, enabling a generic version of this…
-
FDA approval · 2015-08-25FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approves Apotex Corp.'s supplemental application for diltiazem hydrochloride (generic) under an abbreviated new drug application (ANDA).
-
FDA approval · 2015-08-13FDA Approved: PROPAFENONE HCL — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Propafenone hydrochloride (Propafenone HCl) from Actavis Pharma, Inc.
-
FDA approval · 2015-02-17FDA Approved: FLECAINIDE ACETATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for flecainide acetate from Hikma Pharmaceuticals USA Inc., expanding or authorizing changes to this…
-
FDA approval · 2014-09-24FDA Approved: ADENOSINE — Supplemental Application (Mylan Institutional LLC)
The FDA has approved a supplemental application for Adenosine submitted by Mylan Institutional LLC. The approval updates the product’s label…
-
FDA approval · 2014-03-28FDA Approved: ADENOSINE — Original Application (Mylan Institutional LLC)
FDA approved Mylan Institutional LLC's original ANDA for Adenosine, a generic short-acting antiarrhythmic. The approval supports the generic…
-
FDA approval · 2013-08-29FDA Approved: ADENOSINE — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approves Meitheal Pharmaceuticals Inc.'s original application for adenosine (IV), marking the approval of a generic IV formulation of ad…
-
FDA approval · 2012-12-07FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s generic diltiazem hydrochloride (ANDA 202463). The product is indicated for the management of hypertensi…
-
FDA approval · 2012-08-24FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental abbreviated new drug application for diltiazem hydrochloride from Sun Pharmaceutical, a generic calcium channel …
-
FDA approval · 2011-11-29FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Verapamil Hydrochloride from Chartwell RX, LLC.
-
FDA approval · 2011-01-13FDA Approved: ADENOSINE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for adenosine from Mylan Institutional LLC.
-
FDA approval · 2010-11-23FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
FDA's entry shows a supplemental application submission for Cardizem LA (diltiazem hydrochloride extended-release). The sponsor is Bausch He…
-
FDA approval · 2010-08-12FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for verapamil hydrochloride from Mylan Pharmaceuticals Inc., granting/confirming approval for a …
-
FDA approval · 2010-03-15FDA Approved: MATZIM LA — Original Application (Actavis Pharma, Inc.)
FDA approved MATZIM LA, a diltiazem hydrochloride extended-release tablet, under Actavis Pharma's original ANDA.
-
FDA approval · 2009-12-03FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for verapamil hydrochloride by Mylan Pharmaceuticals Inc., enabling the generic version to be market…